Asthma

A new review article highlights the importance of developing asthma action plans and clear lines of communication.

Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, talks about the shift in focus that is needed to improve care for patients with asthma.

This new study of primary care patients in the United Kingdom investigated the impact of Headspace, a mindfulness-focused app, on asthma-related quality of life (QOL).

Michael E. Wechsler, MD, a pulmonologist at National Jewish Health, discusses the challenges associated with differentiating similar eosinophilic conditions, including eosinophilic asthma, from one another.

Study results released earlier this month showcased results in children and adults with uncontrolled asthma. The findings were presented at the European Respiratory Society (ERS) 2021 International Congress.

Michael E. Wechsler, MD, a pulmonologist at National Jewish Health, details the ways that the treatment of eosinophilic asthma differs from other forms of asthma.

Using the argument that regularly taking medication is a great way to earn parents' trust is a great tactic to encourage children and teenagers to remain adherent to their asthma therapies, said William "Andy" Nish, MD, an allergist and immunologist in Georgia.

Randomized controlled trials on asthma hospitalization prevention are limited, but patient and caregiver education should be a top priority, investigators said.

There are several biomarkers that act as therapeutic targets for asthma, and plenty of medications aimed at inhibiting them, according to William "Andy" Nish, MD.

Researchers assess mortality rates among those with just asthma, just atopic dermatitis, and individuals with both conditions in Denmark.

Dupilumab is effective for atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, but a recent presentation noted the payer challenge in placing the biologic in an optimal tier.